What is Veru Inc (VERU) stock price today?

Veru Inc (VERU) currently trades at $2.25 per share. The stock has a market capitalization of $36.76M and a P/E ratio of —x.

Is VERU stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, Veru Inc has a Smart Value Score of 41/100 (Grade D), resulting in a "Sell" investment rating. The Piotroski F-Score is —/9 and Altman Z-Score is —.

What is Veru Inc's revenue and earnings?

Veru Inc has trailing twelve-month (TTM) revenue of $16.89M with profit margins of 0.00%. Earnings per share (EPS) is $-1.21.

Is VERU stock overvalued or undervalued?

Based on our DCF model, Veru Inc's intrinsic value is $3.50, representing a margin of safety of 36.00%. The stock currently trades at a P/E of —x.

VERU

Veru Inc

NASDAQ: VERU · HEALTHCARE · BIOTECHNOLOGY

$2.25

+0.45% today

Updated 2026-04-30

Market cap

$36.76M

P/E ratio

—

P/S ratio

1.79x

EPS (TTM)

$-1.21

Dividend yield

—

52W range

$2 – $7

Volume

0.1M

Market cap

$36.76M

P/E ratio

—

P/S ratio

1.79x

EPS (TTM)

$-1.21

Dividend yield

—

52W range

$2 – $7

Volume

0.1M

WallStSmart proprietary scores

out of 100

Grade: D

Sell

Investment rating

5.7

Growth

C+

5.0

Quality

C+

3.0

Profitability

5.7

Valuation

C+

—/9

Piotroski F-Score

—

Altman Z-Score

—

Industry rank

—

View all highly rated stocks (75+) →206 stocks currently score above 75

Price targets

Analyst target

$25.00

+1011.11%

12-Month target

—

Intrinsic (DCF)

$3.50

Margin of safety

+36.00%

0 Strong Buy2 Buy0 Hold0 Sell0 Strong Sell

Price chart

X-Ray snapshot

Strengths

+ Revenue growth 18.30% QoQ

+ 36.00% below intrinsic value

Risks

- Thin margins at 0.00%

- Negative free cash flow $-6.17M

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$39.35M	$16.30M	$16.89M	$0.00	$16.89M
Net income	$-83.78M	$-93.15M	$-37.80M	$-22.73M	$-5.33M
EPS	—	—	—	—	$-1.21
Free cash flow	$-48.24M	$-88.68M	$-21.84M	$-30.04M	$-6.17M
Profit margin	-212.88%	-571.60%	-223.86%	—	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
VERU	$36.76M	41	5.7	3.0	5.7	5.0	+36.00%	Hold
LLY	$760.43B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.28B	59	4.7	9.0	3.3	6.0	-43.54%	Buy
ABBV	$360.63B	63	4.0	8.0	4.7	5.0	-29.31%	Buy
UNH	$336.47B	54	5.3	5.5	7.3	4.8	+42.09%	Buy
AZN	$287.11B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

Veru Inc trades at $2.25. Our Smart Value Score of 41/100 indicates the stock is fair. TTM revenue stands at $16.89M. Our DCF model estimates intrinsic value at $3.50.

Frequently asked questions

What is Veru Inc's stock price?

Veru Inc (VERU) trades at $2.25.

Is Veru Inc overvalued?

Smart Value Score 41/100 (Grade D, Sell). DCF value $3.50.

What is the price target of Veru Inc (VERU)?

The analyst target price is $25.00, representing +1011.1% upside from the current price of $2.25.

What is the intrinsic value of Veru Inc (VERU)?

Based on our DCF model, intrinsic value is $3.50, a +36.0% margin of safety versus $2.25.

What is Veru Inc's revenue?

TTM revenue is $16.89M.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio1.79x

ROE-60.30%

Beta-1.34

50D MA$2.41

200D MA$3.07

Shares out0.02B

Float0.01B

Short ratio—

Avg volume0.1M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

VERU vs LLY →VERU vs JNJ →VERU vs ABBV →Stock screener →